Get the Stockscreener App
117.45
1.13%
-1.46
Overview
News
Price History
Option Chain
Financials
Why A Down?
Discussions
Forecast
Stock Split
Dividend History
Agilent Technologies Inc stock is traded at $117.45, with a volume of 159.28K.
It is down -1.13% in the last 24 hours and up +1.86% over the past month.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
See More
Previous Close:
$118.91
Open:
$116.68
24h Volume:
159.28K
Relative Volume:
0.07
Market Cap:
$32.37B
Revenue:
$6.63B
Net Income/Loss:
$1.17B
P/E Ratio:
29.00
EPS:
4.05
Net Cash Flow:
$1.19B
1W Performance:
+1.53%
1M Performance:
+1.86%
6M Performance:
-15.42%
1Y Performance:
-9.96%
1-Day Range:
$116.45
$117.99
1-Week Range:
$115.77
$122.83
52-Week Range:
$96.43
$153.84
Agilent Technologies Inc Stock (A) Company Profile
Name
Agilent Technologies Inc
Sector
Industry
Phone
(408) 345-8886
Address
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Compare A with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
A
Agilent Technologies Inc
|
117.37 | 32.37B | 6.63B | 1.17B | 1.19B | 4.05 |
|
TMO
Thermo Fisher Scientific Inc
|
408.43 | 150.38B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
202.43 | 137.52B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
525.23 | 42.00B | 3.93B | 894.97M | 837.70M | 10.82 |
|
IQV
Iqvia Holdings Inc
|
157.89 | 25.50B | 15.50B | 1.33B | 2.16B | 7.34 |
Agilent Technologies Inc Stock (A) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-10-25 | Upgrade | Barclays | Underweight → Equal Weight |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jul-10-24 | Upgrade | Citigroup | Neutral → Buy |
| Jun-27-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Apr-05-24 | Upgrade | Stifel | Hold → Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Dec-12-23 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-17-23 | Downgrade | UBS | Buy → Neutral |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-31-23 | Downgrade | Evercore ISI | Outperform → In-line |
| May-24-23 | Reiterated | Barclays | Equal Weight |
| May-24-23 | Reiterated | BofA Securities | Buy |
| May-24-23 | Reiterated | Citigroup | Neutral |
| May-24-23 | Reiterated | Credit Suisse | Outperform |
| May-24-23 | Reiterated | Evercore ISI | Outperform |
| May-24-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| May-24-23 | Reiterated | Robert W. Baird | Outperform |
| May-24-23 | Reiterated | SVB Securities | Outperform |
| May-24-23 | Reiterated | Stifel | Hold |
| May-24-23 | Reiterated | TD Cowen | Outperform |
| May-24-23 | Reiterated | Wells Fargo | Overweight |
| May-11-23 | Initiated | Barclays | Equal Weight |
| Jan-10-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-20-22 | Initiated | UBS | Buy |
| Jul-08-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-23-22 | Reiterated | BofA Securities | Buy |
| Feb-23-22 | Reiterated | Citigroup | Buy |
| Feb-23-22 | Reiterated | Cowen | Outperform |
| Feb-23-22 | Reiterated | Evercore ISI | Outperform |
| Feb-23-22 | Reiterated | Stifel | Hold |
| Feb-23-22 | Reiterated | Wells Fargo | Overweight |
| Nov-23-21 | Reiterated | BofA Securities | Buy |
| Nov-23-21 | Reiterated | Cowen | Outperform |
| Nov-23-21 | Reiterated | Stifel | Hold |
| Mar-18-21 | Upgrade | Citigroup | Neutral → Buy |
| Feb-17-21 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-25-20 | Upgrade | UBS | Neutral → Buy |
| Nov-17-20 | Upgrade | Cleveland Research | Neutral → Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-30-20 | Initiated | Atlantic Equities | Neutral |
| Aug-19-20 | Reiterated | BofA Securities | Neutral |
| Aug-19-20 | Reiterated | Citigroup | Neutral |
| Aug-19-20 | Reiterated | Jefferies | Buy |
| Aug-19-20 | Reiterated | Robert W. Baird | Outperform |
| Aug-19-20 | Reiterated | SVB Leerink | Outperform |
| Aug-19-20 | Reiterated | Stifel | Hold |
| Aug-19-20 | Reiterated | Wells Fargo | Overweight |
| Feb-24-20 | Downgrade | Needham | Buy → Hold |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Neutral |
| Nov-26-19 | Reiterated | Needham | Buy |
| Nov-15-19 | Initiated | Stifel | Hold |
| Oct-18-19 | Downgrade | UBS | Buy → Neutral |
| Jul-16-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jul-15-19 | Downgrade | Barclays | Overweight → Equal Weight |
View All
Agilent Technologies Inc Stock (A) Latest News
Quintet Private Bank Europe S.A. Acquires 6,777 Shares of Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Central Valley Advisors LLC Invests $1.85 Million in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Fenimore Asset Management Inc Sells 3,416 Shares of Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Is Agilent Technologies Stock Underperforming the Dow? - MSN
Agilent Technologies (NYSE:A) Unveils Cutting-Edge Lab Innovations At HPLC 2025 Conference - simplywall.st
Agilent to Showcase New Products and Innovations At HPLC 2025 - marketscreener.com
Agilent Technologies’ SWOT analysis: stock upgrade amid uncertain outlook - Investing.com
Here’s Why Agilent (A) Traded Down in Q1 - MSN
Agilent to Showcase New Products and Innovations at HPLC 2025 | A Stock News - GuruFocus
Agilent to Showcase New Products and Innovations at HPLC 2025 - Business Wire
Synthego Prevails In Patent Appeal Confirming Agilent CRISPR Patents Are Invalid - Longview News-Journal
Tounjian Advisory Partners LLC Buys New Shares in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Molecular Diagnostics for Cancer Market Research 2025: Advances in Personalized Medicine and Liquid Biopsies Reshape Industry Landscape - GlobeNewswire Inc.
NBC Securities Inc. Purchases 2,274 Shares of Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Agilent Technologies, Inc. (NYSE:A) Shares Sold by Gateway Investment Advisers LLC - MarketBeat
Fed. Circ. Backs PTAB Invalidation Of Agilent CRISPR Patents - Law360
Agilent Technologies, Inc. (NYSE:A) Receives $140.15 Consensus Target Price from Brokerages - MarketBeat
Fiduciary Financial Group LLC Takes Position in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Godsey & Gibb Inc. Raises Stock Holdings in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Agilent Technologies Inc (A) Stock Price Up 3.58% on Jun 10 - GuruFocus
Is Agilent Technologies Stock Underperforming The Dow? - Barchart.com
$101.5 Bn Oncology Diagnostics Global Markets, 2023-2024 & - GlobeNewswire
Lmcg Investments LLC Lowers Stock Holdings in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Stifel Nicolaus Maintains Buy Rating on Agilent Technologies (A), Sets $151 PT - MSN
Vantage Wealth Raises Position in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Wealth Enhancement Advisory Services LLC Boosts Stock Position in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
GAMMA Investing LLC Raises Stock Holdings in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Czech National Bank Has $7.67 Million Holdings in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Rhumbline Advisers Increases Stake in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Agilent Technologies (NYSE:A) Shares Acquired Rep. Robert Bresnahan, Jr. - MarketBeat
Agilent Technologies' Hidden Growth Engine: How New Acquisitions Are Shaping the Future of Modern Medicine! - Smartkarma
Agilent at Jefferies Conference: Strategic Transformation in Focus - Investing.com
Transcript : Agilent Technologies, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 10 - marketscreener.com
Forensic Genomics Market Research 2025Global Trends, Opportunity, and Forecasts 2020-2030 - GlobeNewswire Inc.
Ex-Agilent executive Philip Binns appointed chair at Lightcast - Business Weekly
Long Read Sequencing Market Key Players Analysis10X Genomics, - openPR.com
gRNA Market Top PlayersThermo Fisher Scientific Inc., Agilent - openPR.com
Leerink Partnrs Has Negative Estimate for A Q3 Earnings - MarketBeat
GAMMA Investing LLC Grows Stock Position in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Leerink Partners Raises Agilent Technologies (NYSE:A) Price Target to $135.00 - MarketBeat
Agilent Technologies Navigates Regulatory and Sustainability Challenges Amidst Global Compliance Pressures - TipRanks
Agilent Technologies (NYSE:A) Shares Gap Up on Better-Than-Expected Earnings - MarketBeat
Agilent Technologies Inc Stock (A) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.75%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):